216095265	216095265	CD	B-NP	O
|	|	NNP	I-NP	O
WMC	WMC	NNP	I-NP	O
|	|	VBD	B-VP	O
79004464	79004464	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4379168	4379168	CD	B-NP	O
|	|	CC	I-NP	O
5/13/2006	5/13/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
GERD	GERD	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/23/2006	5/23/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/26/2006	3/26/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
ROHLMAN	ROHLMAN	NNP	B-NP	O
,	,	,	O	O
DARIO	DARIO	NNP	B-NP	O
405-36-85-7	405-36-85-7	CD	I-NP	O
Ing	Ing	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
2/3/06	2/3/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BOPPRE	BOPPRE	NNP	B-NP	O
,	,	,	O	O
KIRBY	KIRBY	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
PROZAC	PROZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUOXETINE	FLUOXETINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LOPRESSOR	LOPRESSOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ATROVENT	ATROVENT	NNP	B-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
NEB	NEB	NNP	I-NP	O
QID	QID	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/16/06	6/16/06	CD	B-NP	O
by	by	IN	B-PP	O
TROLIO	TROLIO	NNP	B-NP	O
,	,	,	O	O
LONNIE	LONNIE	NNP	B-NP	O
F	F	NNP	I-NP	O
P.	P.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NEPHROCAPS	NEPHROCAPS	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
132995222	132995222	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NEPHROCAPS	NEPHROCAPS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/16/06	6/16/06	CD	B-NP	O
by	by	IN	B-PP	O
WILBURN	WILBURN	NNP	B-NP	O
,	,	,	O	O
RANDY	RANDY	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
18	18	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
ACIPHEX	ACIPHEX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
RABEPRAZOLE	RABEPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/9	1/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
Adv.	Adv.	NN	I-NP	B-protein
as	as	IN	B-PP	O
tol	tol	NN	B-NP	O
.	.	.	O	O

/	/	SYM	O	B-protein
2	2	CD	B-NP	I-protein
gram	gram	NN	I-NP	I-protein
K	K	NN	I-NP	I-protein
+	+	SYM	B-NP	O
,	,	,	O	O
Renal	Renal	JJ	B-NP	O
diet	diet	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Kielty	Kielty	NNP	I-NP	O
8/28	8/28	CD	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	B-protein
,	,	,	O	O
Morphine	Morphine	NN	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
angina	angina	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
DEPRESSION	DEPRESSION	NN	B-NP	O
,	,	,	O	O
OBESITY	OBESITY	NN	B-NP	O
,	,	,	O	O
TAH/BSO	TAH/BSO	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
Dia	Dia	NNP	B-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
-LRB-	-LRB-	SYM	O	O
EF	EF	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
,	,	,	O	O
LVH	LVH	NN	B-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
angina	angina	NN	B-NP	O
,	,	,	O	O
insulin-resistant	insulin-resistant	JJ	B-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
esophageal	esophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
gout	gout	IN	B-PP	O
-LRB-	-LRB-	NNP	B-NP	O
gout	gout	IN	B-PP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
ESRD	ESRD	NNP	B-NP	O
,	,	,	O	O
COPD	COPD	NNP	B-NP	O
,	,	,	O	O
OSA	OSA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
failed	failed	JJ	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
placements	placement	NNS	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
3/19/06	3/19/06	CD	B-NP	O
Coronary	Coronary	JJ	I-NP	O
Catheterization	Catheterization	NN	I-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
instent	instent	JJ	I-NP	O
restenosis	restenosis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
critical	critical	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
Pain	Pain	NNP	I-NP	O
History	History	NNP	I-NP	O
of	of	IN	B-PP	O
Present	Present	NNP	B-NP	O
Illness	Illness	NNP	I-NP	O
Ms.	Ms.	NNP	I-NP	O
Webre	Webre	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75F	75F	NN	I-NP	O
who	who	WP	B-NP	O
began	begin	VBD	B-VP	O
HD	HD	NN	B-NP	O
one	one	CD	I-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
presented	present	VBD	B-VP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
Troponin	Troponin	NN	I-NP	I-protein
2.9	2.9	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
s/p	s/p	NN	B-NP	O
DES	DES	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presents	present	VBZ	B-VP	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
and	and	CC	I-NP	O
sub-sternal	sub-sternal	JJ	I-NP	O
burning	burning	NN	I-NP	O
sensation	sensation	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
more	more	RBR	B-ADJP	O
intense	intense	JJ	I-ADJP	O
,	,	,	O	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
anginal	anginal	JJ	I-NP	O
pain	pain	NN	I-NP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Episodes	Episode	NNS	B-NP	O
started	start	VBD	B-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
occurring	occur	VBG	B-VP	O
when	when	WRB	B-ADVP	O
lying	lie	VBG	B-VP	O
down	down	RP	B-PRT	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
bed	bed	NN	B-NP	O
and	and	CC	O	O
last	last	JJ	B-NP	B-protein
1	1	CD	I-NP	I-protein
hour	hour	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
spontaneously	spontaneously	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
,	,	,	O	O
about	about	IN	B-NP	O
a	a	DT	I-NP	O
2-3/10	2-3/10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Second	Second	JJ	B-NP	O
identical	identical	JJ	I-NP	O
episode	episode	NN	I-NP	O
1	1	CD	I-NP	O
day	day	NN	I-NP	O
PTA	PTA	NN	I-NP	O
.	.	.	O	O

Neither	Neither	CC	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
radiating	radiate	VBG	B-VP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
DOE	DOE	NNP	B-NP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
to	to	TO	B-PP	O
PCPs	PCP	NNS	B-NP	O
office	office	NN	I-NP	O
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
and	and	CC	O	O
relieved	relieve	VBN	B-VP	O
with	with	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

Sent	Sent	JJ	B-ADJP	O
to	to	TO	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
another	another	DT	B-NP	O
episode	episode	NN	I-NP	O
occurred	occur	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
nitro	nitro	NN	B-NP	O
.	.	.	O	O

Received	Received	NNP	B-NP	O
BB	BB	NNP	I-NP	O
and	and	CC	O	O
ASA	ASA	NNP	B-NP	O
in	in	IN	B-PP	O
ED	ED	NNP	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
missing	miss	VBG	B-VP	O
any	any	DT	B-NP	O
plavix	plavix	NN	I-NP	O
since	since	IN	B-PP	O
DES	DES	NNP	B-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
state	state	NN	B-NP	O
plavix	plavix	NN	I-NP	O
has	have	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
radiating	radiate	VBG	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
F/C	F/C	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

+	+	JJ	B-NP	O
cough	cough	NN	I-NP	O
since	since	IN	B-PP	O
starting	start	VBG	B-VP	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

PMH	PMH	NN	B-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
MR	MR	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
+	+	SYM	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
DEPRESSION	DEPRESSION	NN	B-NP	O
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
,	,	,	O	O
H/O	H/O	NNP	B-NP	O
RT	RT	NNP	I-NP	O
PLEURAL	PLEURAL	NNP	I-NP	O
EFFUSION	EFFUSION	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
?	?	.	O	O

IDIOPATHIC	IDIOPATHIC	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
GOUT	GOUT	NN	B-NP	B-protein
,	,	,	O	O
SLEEP	SLEEP	NN	B-NP	O
APNEA	APNEA	NN	I-NP	O
,	,	,	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
Stent	Stent	NNP	B-NP	O
placed	place	VBN	B-VP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
in	in	IN	B-PP	O
11/3	11/3	CD	B-NP	O
for	for	IN	B-PP	O
NSTEMI	NSTEMI	NNP	B-NP	O
,	,	,	O	O
ESRD	ESRD	NNP	B-NP	B-protein
Admission	Admission	NNP	I-NP	I-protein
Medications	Medications	NNP	I-NP	I-protein
ACIPHEX	ACIPHEX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
RABEPRAZOLE	RABEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
20MG	20MG	NN	I-NP	I-protein
TABLET	TABLET	NN	I-NP	I-protein
DR	DR	NN	I-NP	I-protein
take	take	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ALBUTEROL	ALBUTEROL	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INHALER	INHALER	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFFS	PUFFS	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
30	30	CD	I-NP	I-protein
day	day	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
ALLOPURINOL	ALLOPURINOL	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
take	take	VBP	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
QOD	QOD	NN	I-NP	I-protein
AMBIEN	AMBIEN	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ZOLPIDEM	ZOLPIDEM	NN	I-NP	I-protein
TARTRATE	TARTRATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
10MG	10MG	NN	I-NP	I-protein
TABLET	TABLET	NN	I-NP	I-protein
take	take	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
Tablet	Tablet	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NNP	B-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
insomnia	insomnia	DT	B-NP	I-protein
ASA	ASA	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
x	x	SYM	O	I-protein
100	100	CD	B-NP	I-protein
day	day	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
ATROVENT	ATROVENT	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFFS	PUFFS	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
CALCITRIOL	CALCITRIOL	NNP	I-NP	I-protein
1.5	1.5	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q	Q	NNP	I-NP	O
Mon	Mon	NNP	I-NP	O
,	,	,	O	O
fri	fri	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
325MG	325MG	NN	I-NP	O
TABLET	TABLET	NN	I-NP	O
take	take	VB	B-VP	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
insulin	insulin	NN	I-NP	O
BD	BD	NN	I-NP	O
syringe	syringe	NN	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
3CC	3CC	NN	I-NP	O
SC	SC	NN	I-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
ISORDIL	ISORDIL	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
40MG	40MG	NNP	I-NP	O
TABLET	TABLET	NN	I-NP	B-protein
take	take	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
Tablet	Tablet	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	VBZ	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10UNITS	10UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
Qhs	Qhs	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
80MG	80MG	NN	I-NP	O
TABLET	TABLET	NN	I-NP	O
take	take	NN	I-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
TABLET	TABLET	NN	I-NP	O
take	take	VB	B-VP	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
TAB	TAB	NN	I-NP	O
SUBL	SUBL	NN	I-NP	O
take	take	VBP	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
SL	SL	NN	I-NP	I-protein
q5min	q5min	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
PLAVIX	PLAVIX	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
75MG	75MG	NN	I-NP	I-protein
TABLET	TABLET	NN	I-NP	I-protein
take	take	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
PROCRIT	PROCRIT	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
EPOETIN	EPOETIN	NNP	I-NP	I-protein
ALFA	ALFA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
PROZAC	PROZAC	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SS	SS	NNP	I-NP	O
VALIUM	VALIUM	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
take	take	VB	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
ZAROXOLYN	ZAROXOLYN	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PRN	PRN	NN	I-NP	O
For	For	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
per	per	IN	B-PP	O
RNP	RNP	NN	B-NP	B-protein
or	or	CC	O	O
MD	MD	NNP	B-NP	O
ALLERGIES	ALLERGIES	NNP	I-NP	O
Penicillins	Penicillins	NNP	I-NP	O
TONGUE	TONGUE	NNP	I-NP	O
SWELLING	SWELLING	NNP	I-NP	O
Morphine	Morphine	NNP	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
Codeine	Codeine	NNP	I-NP	O
Mental	Mental	NNP	I-NP	O
Status	Status	NNP	I-NP	O
Change	Change	NNP	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Social	Social	NNP	B-NP	O
History	History	NNP	I-NP	O
Quit	Quit	NNP	I-NP	O
tob	tob	NN	I-NP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
,	,	,	O	O
smoked	smoke	VBD	B-VP	O
50	50	CD	B-NP	O
pack	pack	NN	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
EtOH	EtOH	NN	I-NP	B-protein
.	.	.	O	O

Lives	Life	NNS	B-NP	O
alone	alone	RB	B-ADVP	O
in	in	IN	B-PP	O
Litrouge	Litrouge	NNP	B-NP	O
Ry	Ry	NNP	I-NP	O
Go	Go	NNP	I-NP	O
Vital	Vital	NNP	I-NP	O
Signs	Signs	NNP	I-NP	O
Blood	Blood	NNP	I-NP	O
Pressure	Pressure	NNP	I-NP	O
:	:	:	O	O
144/74	144/74	CD	B-NP	O
Left	Left	NNP	I-NP	O
Arm	Arm	NNP	I-NP	O
Pulse	Pulse	NNP	I-NP	O
:	:	:	O	O
89	89	CD	B-NP	O
Regular	Regular	JJ	I-NP	O
Weight	Weight	NN	I-NP	O
:	:	:	O	O
210	210	CD	B-NP	O
Pounds	Pound	NNS	I-NP	O
SO2	SO2	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Exam	Exam	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
7cm	7cm	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
CV	CV	NN	B-NP	O
regular	regular	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
SEM	SEM	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
clavicles	clavicle	NNS	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
benign	benign	JJ	I-NP	O
,	,	,	I-NP	O
extr	extr	JJ	I-NP	O
w/o	w/o	NN	I-NP	O
edema	edema	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
poor	poor	JJ	B-NP	O
R	R	NN	I-NP	O
wave	wave	NN	I-NP	O
progression	progression	NN	I-NP	O
v2	v2	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
v4	v4	NN	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
5/24/2006	5/24/2006	CD	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
borderline	borderline	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
mildly	mildly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
is	be	VBZ	B-VP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
septal	septal	JJ	B-ADJP	O
an	an	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
telemetry	telemetry	NN	I-NP	O
for	for	IN	B-PP	O
atypical	atypical	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
and	and	CC	O	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
reports	report	NNS	I-NP	O
having	have	VBG	B-VP	O
taken	take	VBN	I-VP	O
her	her	PRP$	B-NP	O
plavix	plavix	NN	I-NP	O
regularly	regularly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
having	have	VBG	B-VP	O
not	not	RB	I-VP	O
missed	miss	VBN	I-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
burning	burn	VBG	I-VP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
while	while	IN	B-SBAR	O
lying	lie	VBG	B-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
flat	flat	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
troponin	troponin	NN	I-NP	O
0.21-0	0.21-0	CD	I-NP	O
.23	.23	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	B-protein
failure/HD	failure/HD	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
nitro	nitro	NN	B-NP	O
SL	SL	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
critical	critical	JJ	I-NP	O
obstructions	obstruction	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
widely	widely	RB	B-NP	O
patent	patent	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
GERD	GERD	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
cardiac	cardiac	JJ	B-ADJP	O
in	in	IN	B-PP	O
origin	origin	NN	B-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
See	See	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Kastner	Kastner	NNP	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
Plavix	Plavix	NN	B-NP	O
regularly	regularly	RB	B-ADVP	O
and	and	CC	O	O
DO	DO	NN	B-NP	O
NOT	NOT	NN	I-NP	O
MISS	MISS	NN	I-NP	O
A	A	NN	I-NP	O
DOSE	DOSE	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
the	the	DT	B-NP	O
burning	burn	VBG	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
again	again	RB	B-ADVP	O
,	,	,	O	O
you	you	PRP	B-NP	O
may	may	MD	B-VP	O
take	take	VB	I-VP	O
mylanta	mylanta	NN	B-NP	O
or	or	CC	I-NP	O
pepto-bismol	pepto-bismol	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
or	or	CC	O	O
equivalent	equivalent	JJ	B-NP	O
product	product	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
aciphex	aciphex	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
LACHINO	LACHINO	NN	B-NP	O
,	,	,	O	O
ROBERT	ROBERT	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
JI931	JI931	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/3/06	2/3/06	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

